Dubin Glenn 4
4 · C4 Therapeutics, Inc. · Filed Jun 23, 2022
Insider Transaction Report
Form 4
Dubin Glenn
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-22+23,500→ 23,500 totalExercise: $6.06Exp: 2032-06-21→ Common Stock (23,500 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in full upon the earlier to occur of (i) June 22, 2023 and (ii) the next annual meeting of the Issuer's stockholders.